Terms: = Colorectal cancer AND CEBPA, CEBP, 1050, C/EBP-alpha, P49715 AND Prognosis
19 results:
1. Impact of ileostomy in the adjuvant treatment and outcome of colon cancer.
Calderillo-Ruíz G; López-Basave HN; Muñoz-Montaño WR; Díaz-Romero MC; Carbajal-López B; Castillo-Morales C; Pérez-Yépez EA; Albarran-García A
Int J Colorectal Dis; 2023 Jun; 38(1):158. PubMed ID: 37261538
[TBL] [Abstract] [Full Text] [Related]
2. Systematic analysis competing endogenous RNA coexpression network as a potentially prediction prognostic biomarker for colon adenocarcinoma.
Xi J; Zhang H; Li Y; Su H; Chen X; Liang X
Medicine (Baltimore); 2022 Sep; 101(39):e30681. PubMed ID: 36181111
[TBL] [Abstract] [Full Text] [Related]
3. Development of cancer-associated fibroblasts subtype and prognostic model in gastric cancer and the landscape of tumor microenvironment.
Zhang C; Sun D; Li C; Liu Y; Zhou Y; Zhang J
Int J Biochem Cell Biol; 2022 Nov; 152():106309. PubMed ID: 36174922
[TBL] [Abstract] [Full Text] [Related]
4. Pilot proteomic study of locally advanced rectal cancer before and after neoadjuvant chemoradiotherapy indicates high metabolic activity in non-responders' tumor tissue.
Babic T; Lygirou V; Rosic J; Miladinov M; Rom AD; Baira E; Stroggilos R; Pappa E; Zoidakis J; Krivokapic Z; Nikolic A
Proteomics Clin Appl; 2023 Jan; 17(1):e2100116. PubMed ID: 35997210
[TBL] [Abstract] [Full Text] [Related]
5. Cytoproliferative activity in colorectal poorly differentiated clusters: Biological significance in tumor setting.
Caramaschi S; Mangogna A; Salviato T; Ammendola S; Barresi V; Manco G; Canu PG; Zanelli G; Bonetti LR
Ann Diagn Pathol; 2021 Aug; 53():151772. PubMed ID: 34153686
[TBL] [Abstract] [Full Text] [Related]
6. Checkpoint regulator B7x is epigenetically regulated by HDAC3 and mediates resistance to HDAC inhibitors by reprogramming the tumor immune environment in colorectal cancer.
Li Y; Liu Y; Zhao N; Yang X; Li Y; Zhai F; Zang X; Cui W
Cell Death Dis; 2020 Sep; 11(9):753. PubMed ID: 32934224
[TBL] [Abstract] [Full Text] [Related]
7. Increased Risk of Acute Myelogenous Leukemia After Early Onset but Not Late-Onset colorectal cancer.
Lehrer S; Rheinstein PH
Am J Clin Oncol; 2020 Apr; 43(4):263-269. PubMed ID: 31876540
[TBL] [Abstract] [Full Text] [Related]
8. Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy.
Hamfjord J; Guren TK; Dajani O; Johansen JS; Glimelius B; Sorbye H; Pfeiffer P; Lingjærde OC; Tveit KM; Kure EH; Pallisgaard N; Spindler KG
Ann Oncol; 2019 Jul; 30(7):1088-1095. PubMed ID: 31046124
[TBL] [Abstract] [Full Text] [Related]
9. Signet ring cell component predicts aggressive behaviour in colorectal mucinous adenocarcinoma.
Song IH; Hong SM; Yu E; Yoon YS; Park IJ; Lim SB; Kim JC; Yu CS; Kim J
Pathology; 2019 Jun; 51(4):384-391. PubMed ID: 31029443
[TBL] [Abstract] [Full Text] [Related]
10. [Prognostic analysis of gastrointestinal stromal tumors complicated with gastrointestinal bleeding].
Li RT; Zhang GJ; Fu WH; Li WD
Zhonghua Zhong Liu Za Zhi; 2016 May; 38(5):377-80. PubMed ID: 27188612
[TBL] [Abstract] [Full Text] [Related]
11. Establishment of the cancer prevention study II nutrition cohort colorectal tissue repository.
Campbell PT; Deka A; Briggs P; Cicek M; Farris AB; Gaudet MM; Jacobs EJ; Newton CC; Patel AV; Teras LR; Thibodeau SN; Tillmans L; Gapstur SM
Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2694-702. PubMed ID: 25472679
[TBL] [Abstract] [Full Text] [Related]
12. Suitability of circulating miRNAs as potential prognostic markers in colorectal cancer.
Ristau J; Staffa J; Schrotz-King P; Gigic B; Makar KW; Hoffmeister M; Brenner H; Ulrich A; Schneider M; Ulrich CM; Habermann N
Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2632-7. PubMed ID: 25472670
[TBL] [Abstract] [Full Text] [Related]
13. Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101.
Chiorean EG; Ramasubbaiah R; Yu M; Picus J; Bufill JA; Tong Y; Coleman N; Johnston EL; Currie C; Loehrer PJ
Oncologist; 2012; 17(1):13. PubMed ID: 22210086
[TBL] [Abstract] [Full Text] [Related]
14. Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma.
Yuan RH; Wang CC; Chou CC; Chang KJ; Lee PH; Jeng YM
Ann Surg Oncol; 2009 Jun; 16(6):1711-9. PubMed ID: 19357927
[TBL] [Abstract] [Full Text] [Related]
15. Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma?
Cooper R; Sarioğlu S; Sökmen S; Füzün M; Küpelioğlu A; Valentine H; Görken IB; Airley R; West C
Br J Cancer; 2003 Sep; 89(5):870-6. PubMed ID: 12942120
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic influence of tumor-associated eosinophilic infiltrate in colorectal carcinoma.
Fernández-Aceñero MJ; Galindo-Gallego M; Sanz J; Aljama A
Cancer; 2000 Apr; 88(7):1544-8. PubMed ID: 10738211
[TBL] [Abstract] [Full Text] [Related]
17. Glycoprotein CD44 expression in colorectal neoplasms. An immuno-histochemical study including correlation with cathepsin D, extracellular matrix components, p53, Rb, bcl-2, c-erbB-2, EGFR and proliferation indices.
Ioachim E; Goussia A; Agnantis NJ
Virchows Arch; 1999 Jan; 434(1):45-50. PubMed ID: 10071234
[TBL] [Abstract] [Full Text] [Related]
18. Gender related survival in colorectal cancer.
Wolters U; Stützer H; Isenberg J
Anticancer Res; 1996; 16(3A):1281-9. PubMed ID: 8702251
[TBL] [Abstract] [Full Text] [Related]
19. The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment.
Iwama T; Mishima Y; Utsunomiya J
Ann Surg; 1993 Feb; 217(2):101-8. PubMed ID: 8382467
[TBL] [Abstract] [Full Text] [Related]
